Manufacturers are increasing their presence across emerging markets and forging effective distribution networks with regional players. This is helping them expand their outreach and broaden their customer base

NEWARK, Del: The global Laboratory Information Systems (LIS) Market is expected to be worth US$ 1.8 billion by 2021. Sales are expected to increase at a 10.2% CAGR, bringing the market size to US$ 1.9 billion by 2022.

Sales are expected to grow at a healthy 10.2% CAGR over the assessment period, thanks to the aforementioned factors. Between 2022 and 2032, the overall demand for Laboratory Information Systems is expected to grow at a CAGR of 10.2%, totaling around US$ 4.2 million by 2032.

Over the years, the healthcare industry has witnessed massive technological advancements in the form of automation, big data analytics and cloud computing. The most important aspect of the industry is the need to reconcile administrative operations with caregiving operations. This has become possible through the introduction of advanced laboratory testing systems.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-875

Laboratories are the foundational stone for primary healthcare administration. It is the laboratories which are the site for drug development and API formulations. To accelerate the effectiveness of these functions, there is a need to streamline mundane operations such as data collation, assimilation and record maintenance.

The need for systematic data documentation to reduce paperwork is primarily driving the laboratory information systems market. Significant adoption has been witnessed since the COVID-19 pandemic’s onset, enabling healthcare providers to concentrate on drug and vaccine development by smoothening data collection procedures.

Key Findings

• Europe & North America will remain lucrative, accounting for 4/5th of the revenue pie
• Cloud-based laboratory information systems to register maximum increase during the forecast period
• Vendors are increasingly capitalizing on developing LIS software for various healthcare verticals
• Hospital-grade laboratory information systems are gaining significant momentum

“Manufacturers are increasing their presence across emerging markets and forging effective distribution networks with regional players. This is helping them expand their outreach and broaden their customer base,” opines the FMI analyst.

Have a Conversation with the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-875

The primary goal of Point-of-Care Testing is to improve the efficiency and accuracy of laboratory processes while also ensuring regulatory compliance and patient safety. By automating many of the manual processes involved in laboratory testing, LIS software can reduce errors and turnaround times, and improve the quality of test results. Additionally, LIS software can generate reports and provide analytics to help laboratory managers make informed decisions about resource allocation, staffing, and testing protocols.

Competitive Intelligence

The global laboratory information systems market is highly fragmented, characterized by the presence of over 50 vendors. Prominent players include: Cerner Corp., Evident, McKesson, Medical Information Technology (MEDITECH), Epic Systems Corporation, SCC Soft Computer, Roper Technologies Inc., Compu Group Medical and Lab Ware.

With regard to product launches, Cerner Corporation launched Community Works Foundations, a tailor-made cloud-based technology platform for rural and critical access hospitals in July 2020. This technology shall prove instrumental in reducing overhead costs and reducing lengthy implementation procedures. The platform enables hospitals to maintain electronic health records, reducing immense amount of paperwork.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-875

Recently, in August 2020, Medical Information Technology (MEDITECH) partnered with TECHNATION Health in Canada. This collaboration is aimed at enhancing the privacy and security framework of healthcare providers across the nation, ensuring better patient data security. The solution involves provision of cybersecurity and data sovereignty among other objectives.

Key Segments Covered in the Laboratory Information Systems Industry Analysis

By Components:

• Software
• Hardware
• Services

By Delivery Mode:

• On Premise
• Cloud-Based

By End User:

• Hospitals
• Clinics
• Independent Laboratories
• Other

Get Full Access@ https://www.futuremarketinsights.com/reports/laboratory-information-systems-market

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

2. Global Laboratory Information Systems Market Overview

2.1. Introduction

2.1.1. Global Laboratory Information Systems Market Definition

2.1.2. Global Laboratory Information Systems Market Taxonomy

2.2. Market Dynamics

2.2.1. Drivers

2.2.2. Restraints

2.2.3. Opportunity

2.3. Global Laboratory Information Systems Market Trends

Request a Complete TOC of this Report with figures@ https://www.futuremarketinsights.com/toc/rep-gb-875

Have a Look at Related Research Reports of the Healthcare Domain:

Actinomycosis Market Size: The future of the actinomycosis market is looking bright, with growth projections reaching new heights in the coming years. According to Future Market Insights, the market is expected to achieve a staggering value of US$ 50 billion by the end of 2023.

Low-Grade Glioma Therapeutics Market Share: The global low-grade Glioma therapeutics market is expected to garner a market value of US$ 1038 Million in 2023 and is expected to accumulate a market value of US$ 1515.47 Million by registering a CAGR of 4.57% in the forecast period 2023-2033.

Immunology-oncology ELISA Kits Market Growth: The future of the Immunology-oncology ELISA Kits market is looking incredibly bright as demand for these essential tools continues to soar. According to Future Market Insights, the market is expected to be worth US$ 20 billion by 2023, and this figure is only set to grow at a CAGR of 4.1% over the next decade, reaching US$ 30 billion by 2033.

Hypercoagulability Treatment Market Demand: The global hypercoagulability treatment market is expected to garner a market value of US$ 670 million in 2023 and is expected to accumulate a market value of US$ 1,317.99 million by registering a CAGR of 7% in the forecast period 2023 to 2033.

Medical Rehabilitation Robotics Market Opportunity: The global medical rehabilitation robotics market is forecasted to expand at 15.2% CAGR to reach a market valuation of US$ 1.76 Billion by the end of 2033, up from US$ 366.2 Million that was recorded for 2022.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

LinkedIn| Twitter| Blogs | YouTube

For Sales Enquiries: sales@futuremarketinsights.com